Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loopThies Rösner, Stefan Lohse, Matthias Peipp, et al.
Archivum Immunologiae Et Therapiae Experimentalis|May 29, 2010
Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodiesStefan Lohse, Matthias Peipp, Thomas Beyer, et al.
Critical Reviews in Immunology|June 19, 2014
Complement in antibody-based tumor therapyStefanie Derer, Frank J Beurskens, Thies Rosner, et al.
Oncoimmunology|September 18, 2018
Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemiaChristian Kellner, Matthias Peipp, Martin Gramatzki, et al.
Frontiers in Immunology|December 23, 2024
Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expressionOanh T P Nguyen, Sandra Lara, Giovanni Ferro, et al.
Cancers|July 29, 2025
CD19-ReTARGTPR: A Novel Fusion Protein for Physiological Engagement of Anti-CMV Cytotoxic T Cells Against CD19-Expressing MalignanciesAnne Paulien van Wijngaarden, Isabel Britsch, Matthias Peipp, et al.
Clinical and Experimental Immunology|March 24, 2022
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancerMatthias Peipp, Katja Klausz, Ammelie Svea Boje, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 12, 2014
Fc engineering of antibodies and antibody derivatives by primary sequence alteration and their functional characterizationStefanie Derer, Christian Kellner, Thies Rösner, et al.
Cancers|July 2, 2021
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple MyelomaMargaux Lejeune, Elodie Duray, Matthias Peipp, et al.
Oncoimmunology|May 8, 2015
Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicityDaniel Gonnermann, Hans-Heinrich Oberg, Christian Kellner, et al.
Pageof 13